GMR Solutions (GMRS) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- -$1.56
- Estimate
- $0.32
- Surprise
- -582.9%
- Revenue (period 2026-06-30)
- $1.49B
- Score today
- 5.8/10
Revenue source: xbrl.
How the report landed
GMR Solutions (GMRS) reported a wider loss than forecast — diluted EPS of -$1.56 against the $0.32 estimate (a 582.9% shortfall).
Coverage in the report window
- GMR Solutions Affirms FY2026 Sales Guidance of $5.890B-$6.180B vs $6.018B Est — benzinga, 2026-08-12
- GMR Solutions Q2 EPS $(1.84) Misses $(0.16) Estimate, Sales $1.490B Beat $1.469B Estimate — benzinga, 2026-08-12
Where TrendMatrix's rating stands now
TrendMatrix currently rates GMRS Sell at 5.8/10; no pre/post engine snapshot brackets this report.
0 of the last 1 quarters beat the estimate; this quarter's -582.9% surprise compares with a -582.9% four-quarter average. Next scheduled report: 2026-11-16.
What argues against it
- Risk below floor (2.2 < 3.0)
- Momentum score 3.0/10 — below 4.5 minimum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $12.98
- Price target
- $16.31
- Stop
- $12.07
- Upside to target
- +25.7%
- Reward-to-risk
- 2.3:1
Model outputs from TrendMatrix’s engine as of 2026-09-03 — shown for context, not personalized investment advice.
GMRS at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Care Facilities
- Market cap
- $690.9M
- P/E (fwd)
- 7.2
- 52-week range
- $10.26–$15.98
- Off 52-week high
- 18.8%
- RSI (14)
- 47
- Volume vs avg
- 0.07×
- Score today
- 5.8/10